Clinical Trial Update: Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a single dose of sotatercept (ACE-011) on red blood cell mass and plasma volume in participants with solid tumors was terminated; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Solid Tumors | Phase 2 | Status: TERMINATED | Results posted: 2023-11-29